BeiGene, Ltd. (BGNE)


BeiGene, Ltd. (BGNE)

$122.33 USD

1.16 (0.96%)

Updated Jul 17 10:04am

Add BGNE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

BGNE Daily Price Range
BGNE 52-Week Price Range

BGNE News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All BGNE News

BeiGene, Ltd. (BGNE) Company Bio


BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People’s Republic of China. The company was founded in 2010 and is based in the Cayman Islands.

BGNE Stock Chart More Charts


BGNE Price/Volume Stats

Current price $122.33
Prev. close $121.17
Day low $121.18
Day high $122.37
50-day MA $124.22
200-day MA $131.28
52-week high $194.56
52-week low $105.19
Volume 20,527
Avg. volume 319,433
Dividend yield N/A
Market Cap 5.71B

BGNE Social Stream


Loading social stream, please wait...

View Full BGNE Social Stream

BGNE Returns

1-mo 7.32%
3-mo 2.11%
6-mo -14.62%
1-year -25.46%
3-year 314.12%
5-year N/A
YTD -12.78%
2018 43.53%
2017 221.87%
2016 N/A
2015 N/A
2014 N/A


Page generated in 0.4174 seconds.